Rhegmatogenous retinal detachment repair-does age, sex, and lens status make a difference?
Age
Cataract surgery
Pseudophakia
Retinal detachment surgery
Sex
Vitrectomy
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
21
10
2021
accepted:
15
04
2022
revised:
28
01
2022
pubmed:
3
5
2022
medline:
20
9
2022
entrez:
2
5
2022
Statut:
ppublish
Résumé
To analyze the correlation between lens status, age, and sex in the epidemiology and success rates of rhegmatogenous retinal detachment (RRD) surgery. The files of all consecutive patients undergoing vitreoretinal surgery for uncomplicated RRD between Jan 2005 und Dec 2020 were retrospectively reviewed. Successful outcome was defined as no retinal redetachment occurring within 3 months after surgery. 5502 eyes with uncomplicated primary RRD were included. Mean age of the patients was 61.1 years (± 13.6 SD). In the age group over 40 years, a male predominance was found. The percentage of pseudophakic RRD increased from 25 to 40% during the 15 years observation period. In the age group 50 to 69 years, patients with pseudophakic detachments were male in 786 out of 1079 cases (72.9%). In the same age group, 1285 of 2110 (60.9%) patients with phakic RRD were male. Overall, primary success rate after one procedure was 91.2% (5018 of 5502). In the phakic eyes, the primary success rate was higher in those eyes that underwent combined phacovitrectomy (93.0%), compared to those without simultaneous cataract surgery (88.7%; p = 0.002). The ratio of male and female patients with RRD varies between age groups. The proportion of pseudophakic RRD has increased within 15 years. The male predominance in RRD is stronger in pseudophakic than in phakic eyes. In phakic eyes with RRD, a combined phacovitrectomy yielded better anatomical results.
Identifiants
pubmed: 35501490
doi: 10.1007/s00417-022-05674-x
pii: 10.1007/s00417-022-05674-x
pmc: PMC9477924
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3197-3204Informations de copyright
© 2022. The Author(s).
Références
BMC Ophthalmol. 2021 May 3;21(1):196
pubmed: 33941122
Retina. 2015 Feb;35(2):326-33
pubmed: 25158939
Clin Ophthalmol. 2014 Sep 23;8:1957-65
pubmed: 25284982
Eur J Ophthalmol. 2012 Jul-Aug;22(4):635-40
pubmed: 22081671
Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):1109-10
pubmed: 20886223
Clin Ophthalmol. 2018 Aug 15;12:1449-1457
pubmed: 30147297
Am J Ophthalmol. 2020 Nov;219:284-294
pubmed: 32640255
Graefes Arch Clin Exp Ophthalmol. 2021 Aug;259(8):2167-2173
pubmed: 33544177
Ophthalmologe. 2022 Jan;119(Suppl 1):64-70
pubmed: 34137944
Am J Ophthalmol. 2021 Feb;222:318-327
pubmed: 32987002
Am J Ophthalmol. 2005 Feb;139(2):302-10
pubmed: 15733992
Invest Ophthalmol Vis Sci. 2003 May;44(5):1793-800
pubmed: 12714607
JAMA Ophthalmol. 2018 Jul 1;136(7):738-745
pubmed: 29800973
Retina. 2021 Aug 1;41(8):1597-1604
pubmed: 33394996
Can J Ophthalmol. 2015 Oct;50(5):360-6
pubmed: 26455971
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4963-8
pubmed: 20554615
Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1555-1567
pubmed: 33791845
Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):45-52
pubmed: 32813107
Ophthalmology. 2014 Jan;121(1):2-4
pubmed: 24388393
Acta Ophthalmol. 2020 Sep;98(6):603-606
pubmed: 32086859
Eur J Ophthalmol. 2020 Sep;30(5):1120-1126
pubmed: 31177849
Ophthalmologica. 2017;237(2):63-72
pubmed: 28190019
Eye (Lond). 2005 Jun;19(6):665-9
pubmed: 15359254
Clin Ophthalmol. 2020 Aug 12;14:2307-2309
pubmed: 32884232
Ophthalmol Retina. 2021 Nov;5(11):1125-1138
pubmed: 33482399
Clin Ophthalmol. 2019 Aug 21;13:1587-1591
pubmed: 31686771
Retina. 2021 Jan 1;41(1):68-74
pubmed: 32251238